Germline variations of the topoisomerase IIα gene as risk factors for primary gastric B-cell lymphoma

Cancer Letters

Volumn 238, Issue 2, 2006, Pages 295-303

  Hellmig, Stephan ^a   Gieseler, Frank ^a   Ott, Stephan ^b   Rosenstiel, Phillip ^b   Fischbach, Wolfgang ^c   Fölsch, Ulrich Robert ^a   Schreiber, Stefan ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c Aschaffenburg Hospital   (Germany)

Author keywords

Gastric lymphoma; Genetic susceptibility; Mutation detection; TOP2A

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); TOPOISOMERASE II ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME; DISEASE PREDISPOSITION; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; HAPLOTYPE; HELICOBACTER INFECTION; HISTOLOGY; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; STOMACH LYMPHOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; BASE SEQUENCE; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; FEMALE; GERM-LINE MUTATION; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; LYMPHOMA, B-CELL; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STOMACH NEOPLASMS;

HELICOBACTER PYLORI;

EID: 33745050651     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.07.017     Document Type: Article

References (45)

1. Wang J.C. DNA topoisomerases. New break for archaeal enzyme. Nature 386 (1997) 329-331
2. Lang A.J., Mirski S.E., Cummings H.J., Yu Q., Gerlach J.H., and Cole S.P. Structural organization of the human TOP2A and TOP2B genes. Gene 221 (1998) 255-266
3. Goswami P.C., Roti Roti J.L., and Hunt C.R. The cell cycle-coupled expression of topoisomerase IIalpha during S phase is regulated by mRNA stability and is disrupted by heat shock or ionizing radiation. Mol. Cell. Biol. 16 (1996) 1500-1508
4. Escargueil A.E., Plisov S.Y., Filhol O., Cochet C., and Larsen A.K. Mitotic phosphorylation of DNA topoisomerase II alpha by protein kinase CK2 creates the MPM-2 phosphoepitope on Ser-1469. J. Biol. Chem. 275 (2000) 34710-34718
5. Kellner U., Heidebrecht H.J., Rudolph P., Biersack H., Buck F., Dakowski T., et al. Detection of human topoisomerase II alpha in cell lines and tissues: characterization of five novel monoclonal antibodies. J. Histochem. Cytochem. 45 (1997) 251-263
6. Heck M.M., and Earnshaw W.C. Topoisomerase II: a specific marker for cell proliferation. J. Cell. Biol. 103 (1986) 2569-2581
7. Jarvinen T.A., Kononen J., Pelto-Huikko M., and Isola J. Expression of topoisomerase IIalpha is associated with rapid cell proliferation, aneuploidy, and c-erbB2 overexpression in breast cancer. Am. J. Pathol. 148 (1996) 2073-2082
8. Thiede C., Morgner A., Alpen B., Wundisch T., Herrmann J., Ritter M., et al. What role does Helicobacter pylori eradication play in gastric MALT and gastric MALT lymphoma?. Gastroenterology 113 (1997) S61-S64
9. Isaacson P., and Wright D.H. Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer 53 (1984) 2515-2524
10. Schrader C., Meusers P., Brittinger G., Teymoortash A., Siebmann J.U., Janssen D., et al. Topoisomerase IIalpha expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome. Leukemia 18 (2004) 1200-1206
11. Sougioultzis S., Foukas P.G., Tzivras M., Kourtessas D., Gorgoulis V.G., Davaris P., et al. Alterations in the proliferating compartment of gastric mucosa during Helicobacter pylori infection: the putative role of epithelial cells expressing p27(kip1). Mod. Pathol. 16 (2003) 1076-1085
12. O'Reilly S.E., Klimo P., and Connors J.M. The evolving role of etoposide in the management of lymphomas and Hodgkin's disease. Cancer 67 (1991) 271-280
13. Parsonnet J. The incidence of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 9 Suppl. 2 (1995) 45-51
14. Ullrich A., Fischbach W., and Blettner M. Incidence of gastric B-cell lymphomas: a population-based study in Germany. Ann. Oncol. 13 (2002) 1120-1127
15. Hellmig S., Hampe J., and Schreiber S. Helicobacter pylori infection in Africa and Europe: enigma of host genetics. Gut 52 (2003) 1799
16. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H.A., et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404 (2000) 398-402
17. Vassetzky Y.S., Alghisi G.C., and Gasser S.M. DNA topoisomerase II mutations and resistance to anti-tumor drugs. Bioessays 17 (1995) 767-774
18. Fischbach W., Dragosics B., Kolve-Goebeler M.E., Ohmann C., Greiner A., Yang Q., et al. Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma study group. Gastroenterology 119 (2000) 1191-1202
19. Lewin K.J., Ranchod M., and Dorfman R.F. Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease. Cancer 42 (1978) 693-707
20. Carbone P.P., Kaplan H.S., Musshoff K., Smithers D.W., Tubiana M., and Radaszkiewicz T. Report of the committee on Hodgkin's disease staging classification [Clinical staging classification of non-Hodgkin's lymphomas (author's transl Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease. Cancer Res. 31 (1971) 1860-1861
21. Musshoff K. Clinical staging classification of non-Hodgkin's lymphomas (author's transl). Strahlentherapie 153 (1977) 218-221
22. Radaszkiewicz T., Dragosics B., and Bauer P. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. Gastroenterology 102 (1992) 1628-1638
23. Hochhauser D., Stanway C.A., Harris A.L., and Hickson I.D. Cloning and characterization of the 5'-flanking region of the human topoisomerase II alpha gene. J. Biol. Chem. 267 (1992) 18961-18965
24. Hampe J., Wollstein A., Lu T., Frevel H.J., Will M., Manaster C., and Schreiber S. An integrated system for high throughput TaqMan based SNP genotyping. Bioinformatics 17 (2001) 654-655
25. Devlin B., and Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 29 (1995) 311-322
26. Krawczak M., Konecki D.S., Schmidtke J., Duck M., Engel W., Nutzenadel W., et al. Allelic association of the cystic fibrosis locus and two DNA markers, XV2c and KM19, in 55 German families. Hum. Genet. 80 (1988) 78-80
27. Loffeld R.J., Stobberingh E., van Spreeuwel J.P., Flendrig J.A., and Arends J.W. The prevalence of anti-Helicobacter (Campylobacter) pylori antibodies in patients and healthy blood donors. J. Med. Microbiol. 32 (1990) 105-109
28. Seher C., Thierfelder W., and Dortschy R. Helicobacter pylori-prevalence in the German population. Gesundheitswesen 62 (2000) 598-603
29. Hussell T., Isaacson P.G., Crabtree J.E., and Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 342 (1993) 571-574
30. Harris N.L., Jaffe E.S., Diebold J., Flandrin G., Muller-Hermelink H.K., Vardiman J., et al. World health organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting-Airlie house, Virginia, November 1997. J. Clin. Oncol. 17 (1999) 3835-3849
31. Isaacson P.G. Lymphomas of mucosa-associated lymphoid tissue (MALT). Histopathology 16 (1990) 617-619
32. Morgner A., Miehlke S., Fischbach W., Schmitt W., Muller-Hermelink H., Greiner A., et al. Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection. J. Clin. Oncol. 19 (2001) 2041-2048
33. Neubauer A., Thiede C., Morgner A., Alpen B., Ritter M., Neubauer B., et al. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J. Natl Cancer Inst. 89 (1997) 1350-1355
34. Coiffier B., Thieblemont C., Felman P., Salles G., and Berger F. Indolent nonfollicular lymphomas: characteristics, treatment, and outcome. Semin. Hematol. 36 (1999) 198-208
35. Schechter N.R., and Yahalom J. Low-grade MALT lymphoma of the stomach: a review of treatment options. Int. J. Radiat. Oncol. Biol. Phys. 46 (2000) 1093-1103
36. Hande K.R. Clinical applications of anticancer drugs targeted to topoisomerase II. Biochim. Biophys. Acta 1400 (1998) 173-184
37. Piddock L.J., Ricci V., Pumbwe L., Everett M.J., and Griggs D.J. Fluoroquinolone resistance in Campylobacter species from man and animals: detection of mutations in topoisomerase genes. J. Antimicrob. Chemother. 51 (2003) 19-26
38. Goni-Urriza M., Arpin C., Capdepuy M., Dubois V., Caumette P., and Quentin C. Type II topoisomerase quinolone resistance-determining regions of Aeromonas caviae. A. hydrophila, and A. sobria complexes and mutations associated with quinolone resistance. Antimicrob. Agents Chemother. 46 (2002) 350-359
39. Niemann S., Harmsen D., Rusch-Gerdes S., and Richter E. Differentiation of clinical Mycobacterium tuberculosis complex isolates by gyrB DNA sequence polymorphism analysis. J. Clin. Microbiol. 38 (2000) 3231-3234
40. Hinds M., Deisseroth K., Mayes J., Altschuler E., Jansen R., Ledley F.D., et al. Identification of a point mutation in the topoisomerase II gene from a human leukemia cell line containing an amsacrine-resistant form of topoisomerase II. Cancer Res. 51 (1991) 4729-4731
41. Razin S.V. Chromosomal DNA loops may constitute basic units of the eukaryotic genome organization and evolution. Crit. Rev. Eukaryot. Gene. Expr. 9 (1999) 279-283
42. Charron M., and Hancock R. Chromosome recombination and defective genome segregation induced in Chinese hamster cells by the topoisomerase II inhibitor VM-26. Chromosoma 100 (1991) 97-102
43. Pedersen-Bjergaard J., Brondum-Nielsen K., Karle H., and Johansson B. Chemotherapy-related-late occurring-Philadelphia chromosome in AML, ALL and CML. Similar events related to treatment with DNA topoisomerase II inhibitors?. Leukemia 11 (1997) 1571-1574
44. Furukawa M., Uchiumi T., Nomoto M., Takano H., Morimoto R.I., Naito S., et al. The role of an inverted CCAAT element in transcriptional activation of the human DNA topoisomerase IIalpha gene by heat shock. J. Biol. Chem. 273 (1998) 10550-10555
45. Lee M.S., Wang J.C., and Beran M. Two independent amsacrine-resistant human myeloid leukemia cell lines share an identical point mutation in the 170 kDa form of human topoisomerase II. J. Mol. Biol. 223 (1992) 837-843